Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
08/05/1993 | WO1993015062A1 Opioid diarylmethylpiperazines and piperidines |
08/05/1993 | WO1993015059A1 3-phenylureido-azepin-2-ones and -benzazepin-2-ones useful as cholecystokinin antagonists |
08/05/1993 | WO1993015052A1 Compounds as calcium channel antagonists |
08/05/1993 | WO1993015041A1 Ethanolamine derivatives having sympathomimetic and anti-pollakiuria activities |
08/05/1993 | WO1993014790A1 A method for transplanting cells into the brain and therapeutic uses therefor |
08/05/1993 | WO1993014758A1 Use of 3-arylindole and 3-arylindazole derivatives for the treatment of psychoses |
08/05/1993 | WO1993014750A2 Amino acids useful as inhibitors of the advanced glycosylation of proteins |
08/05/1993 | WO1993014747A1 Spray-chilled nabumetone |
08/05/1993 | CA2129027A1 Spray-chilled nabumetone |
08/05/1993 | CA2128699A1 Use of 3-arylindole and 3-arylindazole derivatives for the treatment of psychoses |
08/05/1993 | CA2128630A1 A method for transplanting cells into the brain and therapeutic uses therefor |
08/05/1993 | CA2128536A1 Azabicyclo compounds as calcium channel antagonists |
08/05/1993 | CA2117367A1 3-phenylureido-azepin-2-ones and benzazepin-2-ones useful as cholecystokinin antagonists |
08/05/1993 | CA2107566A1 Ethanolamine derivatives having sympathomimetic and anti-pollakiuria activities |
08/04/1993 | EP0553777A2 Fast dissolving tablet and its production |
08/04/1993 | EP0553658A2 Pharmaceutically active composition from Tanacetum partenium, process of extraction and medicinal composition |
08/04/1993 | EP0553351A1 CRYSTALLINE MODIFICATION OF HYDROCHLORIDE OF 2-DIMETHYLAMINOETHYL ETHER OF n-BUTYLAMINO BENZOIC ACID, METHOD OF OBTAINING IT AND PHARMACEUTICAL PREPARATION FOR ANESTHESIA OF THE EYE BASED THEREUPON |
08/04/1993 | EP0553263A1 1'-aminospiro-[isoquinoline-4(1h),3'-pyrrolidine]- 1,2',3,5'(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors in vivo |
08/04/1993 | EP0553160A1 USE OF ENDO-N-(8-METHYL-8-AZABICYCLO 3.2.1]oct-3-yl)-2,3-DIHYDRO-3,3DIMETHYLINDOLE-1-CARBOXAMIDE IN THE TREATMENT OF DEPENDENCE AND WITHDRAWAL SYNDROME |
08/04/1993 | CN1074903A Substituted hexahyhdroazepinones and tetrahydrobenzazepinones |
08/03/1993 | US5232933 Method for treatment of neurodegenerative diseases |
08/03/1993 | US5232932 Method for treatment of neurodegenerative diseases |
08/03/1993 | US5232931 Sedatives, tranquilizers, antidepressants, neuroleptic agents |
08/03/1993 | US5232929 Treatment and prevention of inflammatory and central nervous system disorders |
08/03/1993 | US5232920 N-(mercaptoalkyl)amides |
08/03/1993 | US5232917 Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
08/03/1993 | CA1320954C .alpha.-adrenergic receptor antagonists |
08/03/1993 | CA1320953C .alpha.-adrenergic receptor antagonists |
08/01/1993 | CA2088464A1 A new pyridine bicyclic derivatives, process for preparing the same, new intermediates obtained, apllication of the same as drugs, and pharmac eutical compositions containing thesame |
07/28/1993 | EP0553016A1 New naphthalene amides and sulfonamides, process for their preparation and pharmaceutical compositions containing them |
07/28/1993 | EP0552462A1 Thiadiazinecarboxamides, process for their preparation and pharmaceuticals |
07/28/1993 | EP0552246A1 Therapeutically useful 2-aminotetralin derivatives |
07/28/1993 | EP0552240A1 New method of treating depression |
07/28/1993 | EP0552237A1 Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of gaba brain receptor ligands |
07/28/1993 | EP0552213A1 1,2,5,6-tetrahydropyridine oxime derivatives |
07/28/1993 | EP0552205A1 New medical use for a certain indole derivative and pharmaceutical composition containing it |
07/28/1993 | EP0552142A1 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
07/28/1993 | EP0432199B1 Composition for the treatment of erectile dysfunction |
07/28/1993 | EP0381696B1 Pharmaceutical composition for the treatment of cocaine addiction |
07/28/1993 | CN1074678A 1,5-benzodiazepine derivatives |
07/28/1993 | CN1074615A Active medicinal component of "Duanshepizu", its extraction process and drug containing it |
07/27/1993 | US5231099 Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs |
07/27/1993 | US5231095 Beta blockers |
07/27/1993 | US5231092 Hexahydroazepine derivatives and pharmaceutical compositions containing them |
07/27/1993 | CA1320725C Hydroquinonylphenyl butyric acid amide derivative |
07/27/1993 | CA1320720C Sialosyl glyceride and process for producing the same |
07/23/1993 | CA2087772A1 Naphthalenic amides and sulfonamides; process for preparing the same and pharmaceutical compositions containing them |
07/22/1993 | WO1993014201A1 Dna encoding a human 5-ht1f receptor and uses thereof |
07/22/1993 | WO1993014102A1 New adenosine derivatives, preparation methods and pharmaceutical compositions containing them |
07/22/1993 | WO1993014092A1 Disubstituted polycyclic systems as cognition enhancers |
07/22/1993 | WO1993014091A1 Alkyl derivatives of trazodone with cns activity |
07/22/1993 | WO1993014090A1 Heterocyclic compounds and their preparation and use |
07/22/1993 | WO1993014089A1 Heterocyclic compounds and their preparation and use |
07/22/1993 | WO1993014087A1 Indole derivatives |
07/22/1993 | WO1993014085A1 Novel neurotransmitter releasers useful for cognition enhancement |
07/22/1993 | WO1993014076A1 Piperazine derivatives as 5-ht receptors antagonists |
07/22/1993 | WO1993014075A1 Carbamate derivatives and their use in medicine |
07/22/1993 | WO1993014074A1 1,5-benzodiazepine derivatives and their use in medicine |
07/22/1993 | WO1993014070A2 Novel imidazole derivatives, their preparation and therapeutic applications |
07/22/1993 | WO1993014067A1 Nitroquinolone derivatives as nmda antagonists |
07/22/1993 | WO1993013764A1 Pharmaceutical preparation of antistress, stress-preventive and nootropic action |
07/22/1993 | WO1993013660A1 Pharmaceutically active antioxydant containing composition and the method of its use to prevent and treat restenosis following angioplasty |
07/22/1993 | WO1993011115A3 Quinolone derivatives and their use as nmda and ampa receptor antagonists |
07/22/1993 | WO1993010783A3 Quinolone derivatives and their use as ampa and nmda receptor antagonists |
07/22/1993 | WO1993010742A3 Chemical compounds, their preparation and use |
07/22/1993 | CA2128234A1 Disubstituted polycyclic systems as cognition enhancers |
07/22/1993 | CA2128233A1 Novel neurotransmitter releasers useful for cognition enhancement |
07/22/1993 | CA2127436A1 Carbamate derivatives and their use in medicine |
07/22/1993 | CA2127251A1 Heterocyclic compounds and their preparation and use |
07/22/1993 | CA2126076A1 Nitroquinolone derivatives as nmda antagonists |
07/22/1993 | CA2125182A1 Piperazine derivatives as 5-ht receptors antagonists |
07/22/1993 | CA2105284A1 Dna encoding a human 5-ht 1f receptor and uses thereof |
07/21/1993 | EP0551963A2 Use of heterocyclic derivatives for the manufacture of medicaments |
07/21/1993 | EP0551849A1 Novel arylcycloalkyl derivatives their production and their use |
07/21/1993 | EP0551432A1 4,5,6,7-tetrahydro-1h-imidazo 4,5-c]pyridine derivatives and analogues as angiotensin ii receptor antagonists |
07/21/1993 | EP0551312A1 Peri-condensed benzazepines |
07/21/1993 | CN1021654C Esters of hexahydro-8-hydroxy-2,6-methylene-2H-quinolizin-3(4H)-one and related compounds |
07/20/1993 | US5229505 CNS and cardiovascular effects |
07/20/1993 | US5229417 2-(3-phenylpropyl)hydrazines and method of treating personality disorders |
07/20/1993 | US5229412 Administering carrier with anxiolytic derivatives of N-(3-/4-indolyloxy/-2-hydroxypropyl)-1,8-diamino-p-menthane |
07/20/1993 | US5229410 Antidepressant, tranquilizers |
07/20/1993 | US5229409 6-substituted-tetrahydrobenz[cd]indoles |
07/20/1993 | US5229399 Analgesics |
07/20/1993 | US5229389 Method for evaluating neuronal activity of a drug |
07/20/1993 | US5229388 3-[4-(1-substituted-4-piperazinyl)butyl]-4-thiazolidinone and related compounds |
07/20/1993 | US5229379 Certain n-substituted-amino-alkane phosphinic acid derivatives having anti-epileptic properties |
07/20/1993 | EP0559825A4 Method and device for treating tobacco addiction. |
07/20/1993 | CA1320495C2 Optically active ketals, processes for their preparation and their use in the synthesis of alpha-arylakanoic acids |
07/20/1993 | CA1320491C Thiadiazole guanidines |
07/20/1993 | CA1320486C .alpha. -adrenergic receptor antagonists |
07/20/1993 | CA1320448C Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes |
07/14/1993 | EP0557290A4 Treatment of aids dementia, myelopathy, peripheral neuropathy, and vision loss. |
07/14/1993 | EP0551219A1 Pyridylsulfonylurea, processes for their preparation and pharmaceutical compositions containing them |
07/14/1993 | EP0550899A1 Process for preparing derivatives of (R) 5-pentylamino-5-oxopentanoic acid with anticholecystokinin activity |
07/14/1993 | EP0550668A1 Ibuprofen-antihistamine combinations |
07/14/1993 | EP0550550A1 3,9-diazabicyclo (3.3.1) nonan-7-yl derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them |
07/14/1993 | EP0550518A1 1-substituted phenoxathiin derivatives as antidepressants |
07/14/1993 | EP0550507A1 Indole ureas as 5 ht receptor antagonist |
07/14/1993 | EP0550444A1 Substituted naphthoxazines useful as dopaminergics |
07/14/1993 | EP0334889B1 Composition for treating obesity |